Skip to main content
ARTL
NASDAQ Life Sciences

Prospectus filed for resale of 9.8M shares and warrants, enabling over 1000% potential dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.26
Mkt Cap
$4.739M
52W Low
$2.955
52W High
$85.8
52W Position info
78% above low
Off High info
94% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ARTL sits 78% above its 52-week low of $2.955 on light trading volume (0.1× avg).

Summary

Artelo Biosciences filed a prospectus to register the resale of up to 9.8 million shares and warrants by selling stockholders, which could result in over 1000% dilution if fully exercised, following a recent $11 million private placement.


Key Events · Financing and Capital Events · ARTL

  • Resale Registration Finalized

    A prospectus was filed for the resale of up to 9,820,294 shares of common stock by selling stockholders, including shares underlying pre-funded and common warrants.

  • Massive Potential Dilution

    The full exercise of these warrants could result in the issuance of 9,739,294 new shares, representing over 1000% dilution compared to the 938,133 shares currently outstanding.

  • Capital Infusion for Operations

    The company previously received $10 million in net proceeds from the underlying private placement and could receive up to an additional $21.5 million from warrant exercises, which is crucial for a company that previously disclosed a going concern warning.

  • Follows Recent Nasdaq Compliance

    This capital event follows the company's recent announcement on April 7, 2026, that it had regained compliance with Nasdaq listing requirements.


Analysis · ARTL · Life Sciences

This 424B3 prospectus finalizes the registration for the resale of a substantial number of shares and warrants previously issued in a private placement that closed on March 30, 2026, and was initially registered via an S-1 on April 7, 2026. The filing makes available for resale up to 9.8 million shares, including those underlying pre-funded and common warrants. With only 938,133 shares currently outstanding, the full exercise of these warrants would lead to over 1000% dilution for existing shareholders. While the company already received $10 million in net proceeds from the private placement and could receive an additional $21.5 million from warrant exercises, which is critical for its operations given a prior going concern warning, the sheer volume of shares registered for resale creates a significant overhang on the stock. This event is a necessary step for the company to secure capital but comes at a very high cost of dilution.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARTL was trading at $5.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $2.96 to $85.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARTL - Latest Insights

ARTL
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.24
Real-time Price: $2.26 info
Change: +$0.020 (+0.89%) info
Market Cap: $1.94M info
ARTL
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.19
Real-time Price: $2.26 info
Change: -$0.930 (-29%) info
Market Cap: $1.94M info
ARTL
Sep 23, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.84
Real-time Price: $2.26 info
Change: -$5.58 (-71%) info
Market Cap: $1.94M info
ARTL
Sep 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $2.26 info
Change: -$2.76 (-55%) info
Market Cap: $1.94M info
ARTL
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.658
Real-time Price: $2.26 info
Change: Reverse Stock Split info
Market Cap: $1.94M info